Advertisement

The Effects of Magnesium and Vitamin E Co-Supplementation on Hormonal Status and Biomarkers of Inflammation and Oxidative Stress in Women with Polycystic Ovary Syndrome

  • Maryam Shokrpour
  • Zatollah AsemiEmail author
Article

Abstract

Synergistic approach of magnesium and vitamin E may benefit clinical symptoms of patients with polycystic ovary syndrome (PCOS) through improving their metabolic profiles and reducing oxidative stress and inflammation. This study was designed to determine the effects of magnesium and vitamin E co-supplementation on hormonal status and biomarkers of inflammation and oxidative stress in women with PCOS. This randomized, double-blind, placebo-controlled trial was conducted among 60 women with PCOS, aged 18–40 years old. Participants were randomly divided into two groups to take 250 mg/day magnesium plus 400 mg/day vitamin E supplements or placebo (n = 30 each group) for 12 weeks. Fasting blood samples were taken at baseline and after the 12-week intervention to quantify related variables. Magnesium and vitamin E co-supplementation resulted in a significant reduction in hirsutism (β − 0.37; 95% CI, − 0.70, − 0.05; P = 0.02) and serum high-sensitivity C-reactive protein (hs-CRP) (β − 0.67 mg/L; 95% CI, − 1.20, − 0.14; P = 0.01), and a significant increase in plasma nitric oxide (NO) (β 3.40 μmol/L; 95% CI, 1.46, 5.35; P = 0.001) and total antioxidant capacity (TAC) levels (β 66.32 mmol/L; 95% CI, 43.80, 88.84; P < 0.001). Overall, magnesium and vitamin E co-supplementation for 12 weeks may benefit women with PCOS on hirsutism, serum hs-CRP, plasma NO, and TAC levels. Clinical trial registration number http://www.irct.ir: IRCT2017082733941N8

Keywords

Supplementation Hormonal status Inflammation Oxidative damage 

Notes

Author’s Contributions

ZA and MS contributed in conception, design, statistical analysis, and drafting of the manuscript. ZA supervised the study.

Funding information

The present study was supported by a grant from the Vice-chancellor for Research, AUMS, Arak, and Iran.

Compliance with Ethical Standards

This randomized, double-blinded, placebo-controlled clinical trial is registered in the Iranian clinical trials website (http://www.irct.ir: IRCT2017082733941N8), has followed the Declaration of Helsinki guideline, and informed consent was given by all participants. The study protocol was approved by the Ethics Committee of Arak University of Medical Sciences (AUMS).

Competing Interests

The authors declare that they have no conflict of interest.

References

  1. 1.
    Bozdag G, Mumusoglu S, Zengin D, Karabulut E, Yildiz BO (2016) The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod 31:2841–2855CrossRefGoogle Scholar
  2. 2.
    Boots CE, Jungheim ES (2015) Inflammation and human ovarian follicular dynamics. Semin Reprod Med 33:270–275CrossRefGoogle Scholar
  3. 3.
    Shorakae S, Teede H, de Courten B, Lambert G, Boyle J, Moran LJ (2015) The emerging role of chronic low-grade inflammation in the pathophysiology of polycystic ovary syndrome. Semin Reprod Med 33: 257–269Google Scholar
  4. 4.
    Artimani T, Karimi J, Mehdizadeh M et al (2018) Evaluation of pro-oxidant-antioxidant balance (PAB) and its association with inflammatory cytokines in polycystic ovary syndrome (PCOS). Gynecol Endocrinol 34:148–152CrossRefGoogle Scholar
  5. 5.
    Chakraborty P, Ghosh S, Goswami SK, Kabir SN, Chakravarty B, Jana K (2013) Altered trace mineral milieu might play an aetiological role in the pathogenesis of polycystic ovary syndrome. Biol Trace Elem Res 152:9–15CrossRefGoogle Scholar
  6. 6.
    Zhang D, Luo WY, Liao H, Wang CF, Sun Y (2008) The effects of oxidative stress to PCOS. Sichuan Da Xue Xue Bao Yi Xue Ban 39:421–423PubMedGoogle Scholar
  7. 7.
    Simental-Mendia LE, Sahebkar A, Rodriguez-Moran M, Zambrano-Galvan G, Guerrero-Romero F (2017) Effect of magnesium supplementation on plasma c-reactive protein concentrations: a systematic review and meta-analysis of randomized controlled trials. Curr Pharm Des 23:4678–4686CrossRefGoogle Scholar
  8. 8.
    Razzaghi R, Pidar F, Momen-Heravi M, Bahmani F, Akbari H, Asemi Z (2018) Magnesium supplementation and the effects on wound healing and metabolic status in patients with diabetic foot ulcer: a randomized, double-blind, placebo-controlled trial. Biol Trace Elem Res 181:207–215CrossRefGoogle Scholar
  9. 9.
    Saboori S, Shab-Bidar S, Speakman JR, Yousefi Rad E, Djafarian K (2015) Effect of vitamin E supplementation on serum C-reactive protein level: a meta-analysis of randomized controlled trials. Eur J Clin Nutr 69:867–873CrossRefGoogle Scholar
  10. 10.
    Dou M, Ma AG, Wang QZ et al (2009) Supplementation with magnesium and vitamin E were more effective than magnesium alone to decrease plasma lipids and blood viscosity in diabetic rats. Nutr Res 29:519–524CrossRefGoogle Scholar
  11. 11.
    Chang W, Ma A, Wang Q, Mao R, Li C (2014) Effects of vitamin E and magnesium on glucolipid metabolism in obese rats. Wei Sheng Yan Jiu 43:713–718PubMedGoogle Scholar
  12. 12.
    Barbagallo M, Dominguez LJ, Tagliamonte MR, Resnick LM, Paolisso G (1999) Effects of vitamin E and glutathione on glucose metabolism: role of magnesium. Hypertension 34:1002–1006CrossRefGoogle Scholar
  13. 13.
    Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81:19–25Google Scholar
  14. 14.
    Hatch R, Rosenfield RL, Kim MH, Tredway D (1981) Hirsutism: implications, etiology, and management. Am J Obstet Gynecol 140:815–830CrossRefGoogle Scholar
  15. 15.
    Tatsch E, Bochi GV, Pereira Rda S et al (2011) A simple and inexpensive automated technique for measurement of serum nitrite/nitrate. Clin Biochem 44:348–350CrossRefGoogle Scholar
  16. 16.
    Benzie IF, Strain JJ (1996) The ferric reducing ability of plasma (FRAP) as a measure of “antioxidant power”: the FRAP assay. Anal Biochem 239:70–76CrossRefGoogle Scholar
  17. 17.
    Beutler E, Gelbart T (1985) Plasma glutathione in health and in patients with malignant disease. J Lab Clin Med 105:581–584PubMedGoogle Scholar
  18. 18.
    Janero DR (1990) Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. Free Radic Biol Med 9:515–540CrossRefGoogle Scholar
  19. 19.
    Afshar Ebrahimi F, Foroozanfard F, Aghadavod E, Bahmani F, Asemi Z (2018) The effects of magnesium and zinc co-supplementation on biomarkers of inflammation and oxidative stress, and gene expression related to inflammation in polycystic ovary syndrome: a randomized controlled clinical trial. Biol Trace Elem Res 184:300–307CrossRefGoogle Scholar
  20. 20.
    Asemi Z, Foroozanfard F, Hashemi T, Bahmani F, Jamilian M, Esmaillzadeh A (2015) Calcium plus vitamin D supplementation affects glucose metabolism and lipid concentrations in overweight and obese vitamin D deficient women with polycystic ovary syndrome. Clin Nutr 34:586–592CrossRefGoogle Scholar
  21. 21.
    Foroozanfard F, Jamilian M, Bahmani F et al (2015) Calcium plus vitamin D supplementation influences biomarkers of inflammation and oxidative stress in overweight and vitamin D-deficient women with polycystic ovary syndrome: a randomized double-blind placebo-controlled clinical trial. Clin Endocrinol 83:888–894CrossRefGoogle Scholar
  22. 22.
    Maktabi M, Jamilian M, Asemi Z (2018) Magnesium-zinc-calcium-vitamin D co-supplementation improves hormonal profiles, biomarkers of inflammation and oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. Biol Trace Elem Res 182:21–28CrossRefGoogle Scholar
  23. 23.
    Ebrahimi FA, Samimi M, Foroozanfard F et al (2017) The effects of omega-3 fatty acids and vitamin E co-supplementation on indices of insulin resistance and hormonal parameters in patients with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. Exp Clin Endocrinol Diabetes 125:353–359CrossRefGoogle Scholar
  24. 24.
    Izadi A, Ebrahimi S, Shirzai S et al (2018) Hormonal and metabolic effects of coenzyme q10 and/or vitamin e in patients with polycystic ovary syndrome. J Clin Endocrinol Metab.  https://doi.org/10.1210/jc.2018-01221
  25. 25.
    Mondul AM, Rohrmann S, Menke A et al (2011) Association of serum alpha-tocopherol with sex steroid hormones and interactions with smoking: implications for prostate cancer risk. Cancer Causes Control 22:827–836CrossRefGoogle Scholar
  26. 26.
    Blank SK, McCartney CR, Helm KD, Marshall JC (2007) Neuroendocrine effects of androgens in adult polycystic ovary syndrome and female puberty. Semin Reprod Med 25:352–359CrossRefGoogle Scholar
  27. 27.
    Dokras A, Sarwer DB, Allison KC et al (2016) Weight loss and lowering androgens predict improvements in health-related quality of life in women with PCOS. J Clin Endocrinol Metab 101:2966–2974CrossRefGoogle Scholar
  28. 28.
    Boztosun A, Acmaz G, Ozturk A, Muderris II (2013) Clinical efficacy of low dose flutamide plus Diane-35 in the treatment of idiopathic hirsutism and polycystic ovary syndrome. Ginekol Pol 84:258–262PubMedGoogle Scholar
  29. 29.
    Barbagallo M, Dominguez LJ, Galioto A et al (2003) Role of magnesium in insulin action, diabetes and cardio-metabolic syndrome X. Mol Asp Med 24:39–52CrossRefGoogle Scholar
  30. 30.
    Rizzo MR, Abbatecola AM, Barbieri M et al (2008) Evidence for anti-inflammatory effects of combined administration of vitamin E and C in older persons with impaired fasting glucose: impact on insulin action. J Am Coll Nutr 27:505–511CrossRefGoogle Scholar
  31. 31.
    Petrovic J, Stanic D, Dmitrasinovic G et al (2016) Magnesium supplementation diminishes peripheral blood lymphocyte DNA oxidative damage in athletes and sedentary young man. Oxidative Med Cell Longev 2016(2019643)Google Scholar
  32. 32.
    Moslehi N, Vafa M, Rahimi-Foroushani A, Golestan B (2012) Effects of oral magnesium supplementation on inflammatory markers in middle-aged overweight women. J Res Med Sci 17:607–614PubMedPubMedCentralGoogle Scholar
  33. 33.
    Mortazavi M, Moeinzadeh F, Saadatnia M, Shahidi S, McGee JC, Minagar A (2013) Effect of magnesium supplementation on carotid intima-media thickness and flow-mediated dilatation among hemodialysis patients: a double-blind, randomized, placebo-controlled trial. Eur Neurol 69:309–316CrossRefGoogle Scholar
  34. 34.
    Kasperczyk S, Dobrakowski M, Kasperczyk A et al (2017) alpha-Tocopherol supplementation and the oxidative stress, homocysteine, and antioxidants in lead exposure. Arch Environ Occup Health 72:153–158CrossRefGoogle Scholar
  35. 35.
    Nadeem A, Raj HG, Chhabra SK (2008) Effect of vitamin E supplementation with standard treatment on oxidant-antioxidant status in chronic obstructive pulmonary disease. Indian J Med Res 128:705–711PubMedGoogle Scholar
  36. 36.
    Rajendran S, Willoughby SR, Chan WP et al (2009) Polycystic ovary syndrome is associated with severe platelet and endothelial dysfunction in both obese and lean subjects. Atherosclerosis 204:509–514CrossRefGoogle Scholar
  37. 37.
    Hyderali BN, Mala K (2015) Oxidative stress and cardiovascular complications in polycystic ovarian syndrome. Eur J Obstet Gynecol Reprod Biol 191:15–22CrossRefGoogle Scholar
  38. 38.
    Aneiros E, Philipp S, Lis A, Freichel M, Cavalie A (2005) Modulation of Ca2+ signaling by Na+/Ca2+ exchangers in mast cells. J Immunol 174:119–130CrossRefGoogle Scholar
  39. 39.
    Mazur A, Maier JA, Rock E, Gueux E, Nowacki W, Rayssiguier Y (2007) Magnesium and the inflammatory response: potential physiopathological implications. Arch Biochem Biophys 458:48–56CrossRefGoogle Scholar
  40. 40.
    Jiang Q (2014) Natural forms of vitamin E: metabolism, antioxidant, and anti-inflammatory activities and their role in disease prevention and therapy. Free Radic Biol Med 72:76–90CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Endocrinology and Metabolism Research CenterArak University of Medical SciencesArakIran
  2. 2.Research Center for Biochemistry and Nutrition in Metabolic DiseasesKashan University of Medical SciencesKashanIslamic Republic of Iran

Personalised recommendations